RG
BHVN icon

Redmile Group’s Biohaven BHVN Stock Holding History

Redmile Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-729,515
Closed -$10.3M – 41
2025
Q2 		$10.3M Sell
729,515
-137,939
-16% -$2.46M 1.1% 22
2025
Q1 		$20.9M Sell
867,454
-37,042
-4% -$1.31M 1.97% 15
2024
Q4 		$33.8M Sell
904,496
-129,723
-13% -$6.05M 2.35% 15
2024
Q3 		$51.7M Sell
1,034,219
-53,357
-5% -$2.08M 3.04% 9
2024
Q2 		$37.7M Sell
1,087,576
-75,665
-7% -$2.99M 2.28% 18
2024
Q1 		$63.6M Sell
1,163,241
-281,124
-19% -$13.9M 2.34% 13
2023
Q4 		$61.8M Buy
1,444,365
+925,441
+178% +$28.8M 2.21% 10
2023
Q3 		$13.5M Buy
+518,924
New +$10.8M 0.64% 36

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group's BHVN Position: Q3 2025 in Review

Redmile Group sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 729,515 shares — an estimated $10.3M sold.

Redmile Group first reported a position in BHVN in Q3 2023 and held it in 8 quarters. The position peaked at $63.6M in Q1 2024. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • Redmile Group reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
  • Redmile Group sold 729,515 Biohaven shares in Q3 2025, an estimated $10.3M.
  • Redmile Group first reported a position in Biohaven in Q3 2023 and held it in 8 quarters.
  • Redmile Group's Biohaven position peaked at $63.6M in Q1 2024.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Redmile Group's 13F filing for Q3 2025, filed 14 Nov 2025.